In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDFDifferences in adverse effect profiles between 4 PrEP optionsPotential for HIV resistanceRequirements for compliance and monitoringEvidence in populations with various acquisition behaviorsDrug interaction implications Faculty: Jona Tanguay, MMSc, PA-C, AAHIVSHealth Care Provider and HIV Specialist Whitman-Walker HealthVice President for Education, GLMA: Health Professionals Advancing LGBTQ EqualityClinical Instructor, Yale University School of Nursing Washington, DC Link to full program: https://bit.ly/41WF54o Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios